Plexus (PLXS)
(Delayed Data from NSDQ)
$153.71 USD
-2.17 (-1.39%)
Updated Nov 14, 2024 04:00 PM ET
After-Market: $153.82 +0.11 (0.07%) 7:58 PM ET
1-Strong Buy of 5 1
B Value B Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$153.71 USD
-2.17 (-1.39%)
Updated Nov 14, 2024 04:00 PM ET
After-Market: $153.82 +0.11 (0.07%) 7:58 PM ET
1-Strong Buy of 5 1
B Value B Growth C Momentum B VGM
Zacks News
Plexus (PLXS) Q4 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
Plexus' (PLXS) fourth-quarter results reflect robust revenues from Healthcare/Life Sciences, Industrial/Commercial and Aerospace/Defense sectors.
Plexus (PLXS) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Plexus (PLXS) delivered earnings and revenue surprises of 8.14% and 4.12%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Plexus (PLXS) Q4 Earnings Expected to Decline
by Zacks Equity Research
Plexus (PLXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Plexus (PLXS) Down 0.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Plexus (PLXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Plexus (PLXS) Q3 Earnings Miss Estimates, Revenues Up Y/Y
by Zacks Equity Research
Plexus' (PLXS) third-quarter results benefit from robust revenues from Healthcare/Life Sciences and Aerospace/Defense sectors despite unfavorable mix, which hurt margins.
Plexus (PLXS) Q3 Earnings Miss Estimates
by Zacks Equity Research
Plexus (PLXS) delivered earnings and revenue surprises of -1.22% and 2.49%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Plexus (PLXS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Plexus (PLXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Plexus (PLXS) Down 6.9% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Plexus (PLXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Plexus (PLXS) Q2 Earnings Miss Estimates, Revenues Beat
by Zacks Equity Research
Plexus (PLXS) second-quarter fiscal 2019 results benefit from strong performance of Healthcare/Life Sciences and Aerospace/Defense segments.
Plexus (PLXS) Q2 Earnings Miss Estimates
by Zacks Equity Research
Plexus (PLXS) delivered earnings and revenue surprises of -7.06% and 1.51%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Plexus (PLXS) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Plexus (PLXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Is Plexus (PLXS) Up 10.1% Since Last Earnings Report?
by Zacks Equity Research
Plexus (PLXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Plexus (PLXS) Beats Q1 Earnings Estimates, Revenues Up Y/Y
by Zacks Equity Research
Plexus' (PLXS) first-quarter fiscal 2019 results benefit from strong performance of the Healthcare/Life Sciences segment.
Plexus (PLXS) Tops Q1 Earnings Estimates
by Zacks Equity Research
Plexus (PLXS) delivered earnings and revenue surprises of 1.11% and -0.50%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Plexus (PLXS) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Plexus (PLXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Plexus (PLXS) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Plexus' (PLXS) fiscal fourth-quarter 2018 results benefit from strong performance of the Industrial/Commercial segment and increasing wins from the manufacturing program
Plexus (PLXS) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Plexus (PLXS) delivered earnings and revenue surprises of 10.34% and 1.01%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Plexus (PLXS) Q4 Earnings Preview: How Are Events Shaping Up?
by Zacks Equity Research
Plexus (PLXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Plexus (PLXS) Misses Q3 Earnings Estimates, Beats Revenues
by Zacks Equity Research
Plexus' (PLXS) fiscal third-quarter revenues benefit from strengthening Healthcare/Life Sciences revenues and increasing wins from the manufacturing program.
Why Is Plexus (PLXS) Down 5.2% Since Its Last Earnings Report?
by Zacks Equity Research
Plexus (PLXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Plexus (PLXS) Enters Oversold Territory
by Zacks Equity Research
Plexus Corp. (PLXS) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock
Plexus (PLXS) Q2 Earnings Miss Estimates, Revenues Beat
by Zacks Equity Research
Plexus' (PLXS) second-quarter fiscal 2018 revenues benefit from strengthening Industrial/Commercial segment and solid growth in Healthcare/Life Sciences sector.
Top Ranked Momentum Stocks to Buy for March 23rd
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 23rd:
Plexus (PLXS) Down 1.6% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Plexus (PLXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Plexus (PLXS) Rides on Program Wins, Rising Investments Hurt
by Zacks Equity Research
Customer wins in the industrial and healthcare market is driving Plexus' (PLXS) top line. However, increasing investment remains an overhang.